We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
4.48%
Top 10 Hldgs %
34.74%
Holding
3,215
New
294
Increased
1,348
Reduced
581
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Financials 7.56%
3 Healthcare 5.92%
4 Communication Services 5.21%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLK icon
1751
Westlake Corp
WLK
$10.1B
$18K ﹤0.01%
199
WRB icon
1752
W.R. Berkley
WRB
$26.3B
$18K ﹤0.01%
547
+119
+28% +$4.12K
PACW
1753
DELISTED
PacWest Bancorp
PACW
$18K ﹤0.01%
446
+2
+0.5% +$86
AI icon
1754
C3.ai
AI
$1.62B
$17K ﹤0.01%
265
+48
+22% +$2.98K
AMKR icon
1755
Amkor Technology
AMKR
$13.1B
$17K ﹤0.01%
720
-247
-26% -$5.5K
ARGX icon
1756
argenx
ARGX
$54.2B
$17K ﹤0.01%
55
-8
-13% -$2.27K
ASX icon
1757
ASE Group
ASX
$82.7B
$17K ﹤0.01%
2,088
+285
+16% +$2.29K
CADE
1758
DELISTED
Cadence Bank
CADE
$17K ﹤0.01%
617
+15
+2% +$455
CSGS
1759
DELISTED
CSG Systems International
CSGS
$17K ﹤0.01%
366
-44
-11% -$2K
ESRT icon
1760
Empire State Realty Trust
ESRT
$802M
$17K ﹤0.01%
1,433
+62
+5% +$729
FPI
1761
Farmland Partners
FPI
$424M
$17K ﹤0.01%
1,400
GTES icon
1762
Gates Industrial Corporation Ltd.
GTES
$7.19B
$17K ﹤0.01%
917
HUBB icon
1763
Hubbell
HUBB
$26.7B
$17K ﹤0.01%
90
+20
+29% +$3.78K
IONS icon
1764
Ionis Pharmaceuticals
IONS
$9.46B
$17K ﹤0.01%
428
-2,534
-86% -$99.3K
NUS icon
1765
Nu Skin
NUS
$250M
$17K ﹤0.01%
294
-31
-10% -$1.76K
ONEQ icon
1766
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$17K ﹤0.01%
300
ORA icon
1767
Ormat Technologies
ORA
$6.87B
$17K ﹤0.01%
240
+110
+85% +$7.82K
PLAB icon
1768
Photronics
PLAB
$1.89B
$17K ﹤0.01%
1,278
QLYS icon
1769
Qualys
QLYS
$6.43B
$17K ﹤0.01%
171
-18
-10% -$1.83K
RITM icon
1770
Rithm Capital
RITM
$5.65B
$17K ﹤0.01%
1,636
+412
+34% +$4.38K
SRPT icon
1771
Sarepta Therapeutics
SRPT
$1.81B
$17K ﹤0.01%
219
+39
+22% +$2.96K
STAA icon
1772
STAAR Surgical
STAA
$1.25B
$17K ﹤0.01%
113
+32
+40% +$4.21K
TTEK icon
1773
Tetra Tech
TTEK
$8.97B
$17K ﹤0.01%
690
+275
+66% +$6.92K
VICR icon
1774
Vicor
VICR
$9.63B
$17K ﹤0.01%
165
WKEY
1775
WISeKey
WKEY
$75.1M
$17K ﹤0.01%
480

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $106M of net new capital in Q2 2021, opening 294 new positions and adding to 1,348 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 294 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.